Sentinel node techniques in cancer of the vulva

Current Women's Health Reports

Volumn 3, Issue 1, 2003, Pages 19-26

  de Hullu, Joanne A ^a   van der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISODIUM HYDROGEN PHOSPHATE; EMLA; ISOSULFAN BLUE; NANOCOLLOID; PATENTE BLUE V; SODIUM CHLORIDE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

BIOPSY TECHNIQUE; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; PATIENT SELECTION; PREOPERATIVE EVALUATION; PUNCH BIOPSY; RADIOACTIVITY; REVIEW; SCINTILLATION PROBE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; VULVA CANCER; LYMPH NODE; METHODOLOGY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; VULVA TUMOR;

FEMALE; HUMANS; LYMPH NODES; MELANOMA; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 0038621925     PISSN: 15345874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Hacker NF: Vulvar cancer. In Practical Gynecologic Oncology, 3rd edn. Edited by Berek JS, Hacker NF. Baltimore: Williams & Wilkins; 2000:553-596.
2. FIGO: Stages 1988 (revision). Gynecol Oncol 1989, 35:125-127.
3. Shepherd JH: Staging announcement: FIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 1995, 5:319.
4. Wilkinson EJ, Rico MJ, Pierson KK: Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1982, 1:29-39.
5. Podratz KC, Symmonds RE, Taylor WF, Williams TJ: Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983, 61:63-74.
6. Andersen BL, Hacker NF: Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983, 62:457-462.
7. Burger MPM, Hollema H, Bouma J: The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 1996, 6:318-322.
8. Hacker NF, Nieberg RK, Berek JS, et al.: Superficially invasive vulvar cancer with nodal metastases. Gynecol Oncol 1983, 15:65-77.
9. Stehman F, Bundy B, Thomas G, et al.: Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys 1992, 24:389-396.
10. Hacker NF, Leuchter RS, Berek JS, et al.: Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981, 58:574-579.
11. Schulz MJ, Penalver M: Recurrent vulvar carcinoma in the intervening tissue bridge in early invasive stage I disease treated by radical vulvectomy and bilateral groin dissection through separate incisions. Gynecol Oncol 1989, 35:383-386.
12. Grimshaw RN, Murdoch JB, Monaghan JM: Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions: experience with 100 cases. Int J Gynecol Cancer 1993, 3:18-23.
13. Christopherson W, Buchsbaum HJ, Voet R, Lifschitz S: Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 1985, 21:247-251.
14. Rose PG: Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer 1999, 9:508-511.
15. Hopkins MP, Reid GC, Morley GW: Radical vulvectomy: the decision for the incision. Cancer 1993, 72:799-803.
16. Mäkelä PJ, Leminen A, Kääriäinen M, Lehtovirta P: Pretreatment sonographic evaluation of inguinal lymph nodes in patients with vulvar malignancy. J Ultrasound Med 1993, 5:255-258.
17. Cohn DE, Dehdashti F, Gibb RK, et al.: Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 2002, 85:179-184.
18. Abang Mohammed DK, Uberoi R, de B Lopes A, Monaghan JM: Inguinal node status by ultrasound in vulvar cancer. Gynecol Oncol 2000, 77:93-96.
19. DiSaia PJ, Creasman WT, Rich WM: An alternative approach to early cancer of the vulva. Am J Obstet Gynecol 1979, 133:825-830.
20. Chu J, Tamimi HK, Figge DC: Femoral node metastases with negative superficial inguinal nodes in early vulvar cancer. Am J Obstet Gynecol 1981, 140:337-338.
21. Levenback C, Burke TW, Gershenson DM, et al.: Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994, 84:163-167.
22. Levenback C, Burke TW, Morris M, et al.: Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995, 59:216-220.
23. deCesare SL, Fiorica JV, Roberts WS, et al.: A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997, 66:425-428.
24. DeCicco C, Sideri M, Bartolomei M, et al.: Sentinel node detection by lymphoscintigraphy and gamma detecting probe in patients with vulvar cancer. J Nucl Med 1997, 38:33P.
25. de Hullu JA, Doting MHE, Piers DA, et al.: Sentinel lymph node identification with Technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998, 39:1381-1385.
26. Tavares MGM, Sapienza MT, Galeb NA, et al.: The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med 2001, 28:1597-1604.
27. Molpus KL, Kelley MC, Johnson JE, et al.: Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med 2001, 46:863-869.
28. Makar APH, Scheistroen M, van den Weyngaert D, Tropé CG: Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy [review of literature]. Int J Gynecol Cancer 2001, 11:255-262.
29. Sliutz G, Reinthaller A, Lantzsch T, et al.: Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 2002, 84:449-452.
30. Rodier JF, Janser JC, Routiot T, et al.: Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol Rep 1999, 6:1249-1252.
31. Terada KY, Shimizu DM, Wong JH: Sentinel node dissection and ultrastaging in squmaous cell cancer of the vulva. Gynecol Oncol 2000, 76:40-44.
32. Ansink AC, Sie-Go DMDS, van der Velden J, et al.: Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection. Cancer 1999, 86:652-656.
33. DeCicco C, Sideri M, Grana C, et al.: Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000, 82:295-299.
34. de Hullu JA, Hollema H, Piers DA, et al.: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000, 18:2811-2816.
35. Levenback C, Coleman RL, Burke TW, et al.: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001, 83:276-281.
36. Moore RG, Depasquale SE, Steinhoff MM, et al.: Sentinel node identification and the ability to detect metastastic tumor to inguinal lymph nodes in vulvar malignancies. In Proceedings of the XXXIII Annual meeting of the Society of Gynecologic Oncologists 2002. Miami; 2002:128P.
37. Dunton CJ, Kautzky M, Hanau C: Malignant melanoma of the vulva: a review. Obstet Gynecol Surv 1995, 50:739-746.
38. Raber G, Mempel V, Jackisch C, et al.: Malignant melanoma of the vulva: report of 89 patients. Cancer 1996, 78:2353-2358.
39. Ragnarsson-Olding N, Johansson H, Rutqvist LE, Ringborg U: Malignant melanoma of the vulva and vagina: trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993, 71:1893-1897.
40. Ragnarsson-Olding BK, Kanter-Lewenhsohn LR, Lagerlöf B, et al.: Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer 1999, 86:1273-1284.
41. Veronesi U, Adamus J, Bandiera DC, et al.: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982, 49:2420-2430.
42. De Hullu JA, Hollema H, Hoekstra HJ, et al.: Vulvar melanoma: Is there a role for sentinel lymph node biopsy? Cancer 2002, 94:486-491.
43. Van Diest PJ, Torrenga H, Meijer S, Meijer CJLM: Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol 2001, 20:238-245.
44. Tjan-Heijnen VC, Buit P, de Widt-Evert LM, et al.: Micrometastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 2001, 70:81-88.
45. Essner R, Morton DL: Does the tumor status of the regional lymph node really matter in melanoma? Ann Surg Oncol 2001, 8:749-751.
46. Essner R, Conforti A, Kelley MC, et al.: Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999, 6:442-449.
47. Clary BM, Mann B, Brady MS, et al.: Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 2001, 8:328-337.
48. Morton DL: Lymphatic mapping and sentinel lymphadenectomy for melanoma; past, present, and future. Ann Surg Oncol 2001, 8:22S-28S.
49. Giuliano AE, Haigh PI, Brennan MB, et al.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000, 18:2553-2559.
50. Ross MI: Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001, 8:77S-81S.